The Versatility of Nano-Vesicles

We are the first company to harness nature’s nano-vesicles to construct a universal influenza vaccine candidate that provides robust and durable immunity against multiple influenza strains in preclinical studies. These nano-vesicles have versatility in their applications for other diseases, including coronaviruses, cancer and allergy. Read more here in the Cornell Chronicle

By genetically engineering the surface display of the nano-vesicles , we can exquisitely target specific diseases. These designer nano-vesicles can also be used with a time-release formulation that enables long acting dosing.

Versatope's universal influenza vaccine candidate is ready for scale up and good laboratory practice (GLP) safety studies for an investigative new drug (IND) application.